Sending in Your Referral
Support Us


Coronavirus (COVID-19)

Mar 27 2020
Many people in our community are feeling worried about COVID-19, our team is here to support you. Please visit our dedicated COVID-19 informati...

Team Harley - City2Surf 2017

Jun 27 2017
Mum Danielle puts it beautifully: "Why we started Team Harley: To raise awareness for Congenital Heart Disease in memory of our amazing...

Halor's story

Jun 23 2017
One of our patients, Halor, was featured on The Children's Hospital at Westmead's Facebook page this week:     ...

Kids Heart Research Publications - 2015


Modified Potts shunt in an adult with pulmonary arterial hypertension and recurrent syncope — Three-year follow-up.
International Journal of Cardiology, Jan-2015
Keogh AM, Nicholls M, Shaw M, Dhital K, Weintraub R, Winlaw DS.

Genetic counselling in parents of children with congenital heart disease significantly improves knowledge about causation and enhances psychosocial functioning.
International Journal of Cardiology, Jan-2015
Blue GM, Kasparian NA, Sholler GF, Kirk EP, Winlaw DS.

Ten-year outcomes of Fontan conversion in Australia and New Zealand demonstrate the superiority of a strategy of early conversion.
European Journal of Cardio-Thoracic Surgery, Apr-2015
Poh CL, Cochrane A, Galati JC, Bullock A, Celermajer DS, Gentles T, Plessis du K, Winlaw DS, Hornung T, Finucane K, d'Udekem Y.

Bioengineering and Stem Cell Technology in the treatment of congenital heart disease.
Journal of Clinical Medicine, Apr-2015
Bosman A, Edel M, Blue GM, Dilley RJ, Harvey RP, Winlaw DS.

Next Generation Sequencing in Congenital Heart Disease: gene discovery and clinical application.
Journal of Next Generation: Sequencing and Applications, Apr-2015
Blue GM, Winlaw DS. 

Developmental outcomes at three years of age following major cardiac and non-cardiac surgery in term infants: A population-based study.
Journal of Paediatrics and Child Health., Jun-2015
Walker, K, Loughran-Fowlds A, Halliday R, Holland AJ, Stewart J, Sholler GF, Winlaw DS, Badawi N.

A Universal and Robust Integrated Platform for the Scalable Production of Human Cardiomyocytes From Pluripotent Stem Cells.
STEM CELLS Translational Medicine, Dec-2015
Fonoudi H, Ansari H, Abbasalizadeh S, Larijani MR, Kiani S, Hashemizadeh S, Zarchi AS, Bosman A, Blue GM, Pahlavan S, Perry M, Orr Y, Mayorchak Y, Vandenberg J, Talkhabi M, Winlaw DS, Harvey RP, Aghdami N, Baharvand H.



Return to publications home page

Contact UsPrintBookmark SiteTell a Friend